Anti-mag Igm-associated Demyelinating Polyneuropathy
📧 Sign up to get email alerts when something new happens for Anti-mag Igm-associated Demyelinating Polyneuropathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Zanubritnib and Anti-MAG Neuropathy [Phase 2]
A Phase 2 clinical trial of Zanubritnib for Anti-MAG IgM-associated demyelinating polyneuropathy is listed as not yet recruiting.